| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 805.294.138 $ | +438.780.944 $ | +229,7 % | 15 | 341.818.506 $ | +172.031.659 $ | +218,6 % | 7 | 124.524.732 $ | +14.959.053 $ | +27,9 % | 3 | ||||
| DBV Technologies S.A. | DBVT | → 0 | Schwach | 108.907.111 $ | +89.797.976 $ | +469,9 % | 1 | ||||||||
| Cullinan Therapeutics, Inc. | CGEM | → 0 | Neutral | 108.681.888 $ | +29.522.314 $ | +37,3 % | 1 | 79.159.574 $ | +33.805.345 $ | +74,5 % | 1 | 45.354.229 $ | -12.237.229 $ | -21,2 % | 1 |
| Aktis Oncology, Inc. | AKTS | → 0 | Stark | 86.513.750 $ | +86.513.750 $ | 1 | |||||||||
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Schwach | 56.358.865 $ | +10.302.521 $ | +22,4 % | 1 | 46.056.344 $ | +15.666.748 $ | +51,6 % | 1 | ||||
| Liquidia Corp | LQDA | → 0 | Neutral | 53.030.663 $ | +4.714.691 $ | +9,8 % | 1 | 48.315.972 $ | +43.767.972 $ | +962,4 % | 1 | ||||
| ALUMIS INC. | ALMS | → 0 | Neutral | 52.575.234 $ | +29.131.792 $ | +124,3 % | 1 | ||||||||
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Neutral | 52.311.924 $ | +11.236.746 $ | +27,4 % | 1 | 41.075.178 $ | +13.164.759 $ | +47,2 % | 1 | ||||
| Revolution Medicines, Inc. | RVMD | → 0 | Schwach | 49.283.966 $ | +9.007.191 $ | +22,4 % | 1 | 40.276.775 $ | +25.532.558 $ | +173,2 % | 1 | ||||
| AGIOS PHARMACEUTICALS, INC. | AGIO | → 0 | Neutral | 44.190.810 $ | +8.712.997 $ | +24,6 % | 1 | 35.477.813 $ | +35.477.813 $ | 1 | |||||
| Trevi Therapeutics, Inc. | TRVI | → 0 | Neutral | 39.350.270 $ | -1.804.059 $ | -4,4 % | 1 | 41.154.329 $ | +9.980.691 $ | +32,0 % | 1 | ||||
| CORCEPT THERAPEUTICS INC | CORT | → 0 | Neutral | 39.733.567 $ | +39.733.567 $ | 1 | |||||||||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Neutral | 35.580.569 $ | +35.580.569 $ | 1 | |||||||||
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 34.233.254 $ | +12.467.766 $ | +57,3 % | 1 | ||||||||
| MoonLake Immunotherapeutics | MLTX | → 0 | Schwach | 33.758.568 $ | +18.958.017 $ | +128,1 % | 1 | ||||||||
| Travere Therapeutics, Inc. | TVTX | → 0 | Schwach | 33.672.274 $ | +33.672.274 $ | 1 | |||||||||
| Evommune, Inc. | EVMN | → 0 | Neutral | 33.470.290 $ | +31.535.353 $ | +1.629,8 % | 1 | ||||||||
| Avidity Biosciences, Inc. | RNA | → 0 | 33.114.159 $ | +11.529.534 $ | +53,4 % | 1 | |||||||||
| 805.294.138 $ | +438.780.944 $ | +229,7 % | 15 | 341.818.506 $ | +172.031.659 $ | +218,6 % | 7 | 124.524.732 $ | +14.959.053 $ | +27,9 % | 3 | ||||